Duck hepatitis bivalent live vaccines and preparation method thereof
The invention relates to duck hepatitis bivalent live vaccines and a preparation method thereof. According to the invention, 1) SPF chicken embryos are inoculated with vaccine strains of the duck hepatitis bivalent live vaccines, namely DHV-1 QL1 strains, through allantoic cavities for culture, and...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to duck hepatitis bivalent live vaccines and a preparation method thereof. According to the invention, 1) SPF chicken embryos are inoculated with vaccine strains of the duck hepatitis bivalent live vaccines, namely DHV-1 QL1 strains, through allantoic cavities for culture, and are inoculated with DHV-3 QL3 strains through chorioallantoic membranes or yolk sacs for culture, the antigen contents of the prepared vaccines are high, and all not less than 10ELD50/ml, so that the duck hepatitis bivalent live vaccines have the characteristics of good safety and excellent immunogenicity, and break through limitations of DHV-3 type virus strains which only can be proliferated in duck embryos; 2) virus solutions cultured by the SPF chicken embryos lower risks of exogenous pathogenic microbial contamination, improve labor efficiency and reduce production costs, thereby being suitable for mass production; 3) the bivalent live vaccines disclosed by the invention can prevent DHV-1 type and DHV-3 t |
---|